MedTrace Logo

Study to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy

NCT07285356 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2025-12-16

No results posted yet for this study

Summary

The primary objective of this randomized clinical trial is to assess whether the use of surgical gloves during treatment can prevent the occurrence of oxaliplatin-induced peripheral neuropathy.

Conditions

Interventions

DEVICE

Surgical Gloves

During each chemotherapy cycle, patients in the experimental group will wear compressive surgical gloves (one size smaller than recommended based on palmar surface measurement) on both hands, which will be put on 30 minutes before the infusion and remain in place until 30 minutes after the end of the chemotherapy infusion.

Sponsors & Collaborators

  • Hospital do Cancer de Londrina

    collaborator UNKNOWN

  • AC Camargo Cancer Center

    lead OTHER

Principal Investigators

  • Bruna Catin Kupper, Nurse, PhD · AC Camarco Cancer Center

  • Éverton Germano Melo, Medical Doctor · Londrina Cancer Hospital

  • Virgilio Souza Silva, Medical Doctor, PhD · AC Camargo Cancer Center

  • Karina Oliveira Ribeiro, Nurse · AC Camargo Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-06
Primary Completion
2026-09-18
Completion
2026-09-18

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07285356 on ClinicalTrials.gov